NFKB1 and Parkinson disease: In turn, HTHQ administration to PD animals resulted in a decrease in the severity of inflammatory processes, as evidenced by a decrease in MPO activity, serum IgG level, expression of p65 NF-κB, and mRNA content of proinflammatory genes in the rat brain.